Adenovirus vectors expressing suicide genes represent a promising approach for cancer gene therapy. We wanted to determine whether the virion host shutoff ( vhs ) gene of herpes simplex virus could be used as a suicide gene for gene therapy of glioblastomas. The vhs gene was cloned downstream of the glial fibrillary acidic protein promoter to direct tissue -specific expression, and recombinant adenoviruses were generated in 293 cells. Viruses, which contained the vhs gene but did not express it, could readily be isolated; however, we were unable to plaque purify viruses that expressed vhs protein. We constructed a derivative of 293 cells expressing an antisense RNA to the vhs gene and used them to generate adenovirus vectors that express vhs protein. These cells were used to complement vhs -expressing adenoviruses through three rounds of plaque purification. This approach could be generalized to produce adenovirus vectors expressing other toxic transgenes. Cancer Gene Therapy ( 2001 ) 8, 566 -572 
R ecombinant adenovirus vectors may have particular utility in gene therapy applications in which short -term expression of the transgene is desired, such as cancer. Tumor-specific, replication -competent adenoviruses and adenovirus vectors expressing suicide genes or proapoptotic genes are in various stages of development. 1 In the case of gene therapy for glioblastomas, adenovirus vectors expressing suicide genes, such as herpes simplex virus thymidine kinase (HSV-tk ) or Escherichia coli cytosine deaminase, 2, 3 or proapoptotic genes, such as Fas ligand, p53, or caspase-8, 4 -6 are being tested for their efficacy in killing tumors in various model systems.
The HSV virion host shutoff (vhs ) gene is responsible for the shutoff of host protein synthesis in HSV-infected cells. The vhs protein is an RNase, degrading both host and viral mRNA ( reviewed in Ref. 7 ) . Expression of the vhs gene alone reduces expression of a cotransfected reporter gene 8, 9 and inhibits replication of human immunodeficiency virus ( HIV ) 10 in transient transfection experiments. Thus, it was suggested that vhs could be used as a suicide gene for HIV gene therapy. 10 One underappreciated aspect of this work is the difficulty in obtaining recombinant adenoviruses that express a toxic transgene. Indeed, several groups have reported difficulties in producing adenovirus vectors expressing Fas ligand, and have had to construct new complementing cell lines. 11 -13 In these cases, the expression of the baculovirus CrmA gene in 293 cells enabled the investigators to produce Fas ligandexpressing adenoviruses.
We describe the generation of adenovirus vectors, which express the vhs gene of HSV type 1 ( HSV-1 ). We were unable to produce vectors that expressed vhs using 293 cells due to the apparent toxicity of the vhs protein. We constructed a derivative of 293 cells that expresses an antisense RNA to the vhs transgene. This cell line has enabled us to produce and plaque -purify recombinant adenovirus expressing vhs protein.
MATERIALS AND METHODS

Construction of the transfer vector
The murine glial fibrillary acidic protein ( gfap ) promoter was amplified from DNA isolated from NIH 3T3 cells ( Qiagen Tissue DNA kit, Qiagen, Chatsworth, CA ) using the primers 5 0 -GGAAGCTTCTGCAGCTAGAACTTGG -3 0 and 5 0 -GGGTACCTGCCCTGCCTCTGC -3 0 , introducing a HindIII site and a KpnI site at the 5 0 and 3 0 ends, respectively, cloned into pHook-2 (Invitrogen, Carlsbad, CA ), and sequenced. The 1500 base pair (bp ) vhs gene was amplified from DNA isolated from HSV-1 (McKrae strain ) -infected BSC -1 cells using the primers 5 0 -GGGTACCGCAGTTACAATTGACCTG -3 0 and 5 0 -GGTCTAGACGCTCGTCTGACG -3 0 , introducing a KpnI site and a XbaI site at the 5 0 and 3 0 ends, respectively. Polymerase chain reaction ( PCR ) reactions to obtain DNA fragments for cloning were performed using Pfu polymerase ( Stratagene, La Jolla, CA ) with 15 rounds of amplification. The resulting fragment was cloned into pUC19, sequenced, and was found to be wild type. 
Construction of the viral backbone
The sequences from nt 4281 through the HindIII site at nt 6241 were amplified from Ad5 DNA, introducing an EcoRI site at nt 4281. The fragment was ligated to Ad5 sequences 6241 -10589 ( HindIII -XbaI ) and EcoRIXbaI-digested pUC19 DNA. This fragment was then ligated with Ad fragments 10589 -17772 ( XbaI-SphI ) and 17772 -21562 (SphI-BamHI ) into EcoRI-BamHIdigested pUC19 DNA. The right 1005 nt of the viral genome were amplified, introducing a ClaI site at the right terminus. After digestion with HindIII and ClaI, it was ligated to BamHI -ClaI -digested pBR322 along with Ad fragments 21562 -29509 (BamHI -NotI), 29509 -32464 ( NotI-BstXI ), and 32464 -34930 (BstXI -HindIII ) . Finally, the nt 4281 -21562 ( EcoRI -BamHI ) and 21562 -35935 (BamHI -ClaI) fragments were cloned into EcoRI-ClaI -digested pBR322 to yield the plasmid pAd12-100.
Transfection of 293 cells to generate recombinant virus
The transfer vector and virus backbone plasmid DNA were purified using the EndoFree plasmid maxiprep kit ( Qiagen ). pTranvhs1 was linearized with EcoRI and pAd12 -100 was linearized with ClaI to free the ITRs, the plasmid DNA was purified from the restriction digests using QIAEX II (Qiagen ) , and ethanol-precipitated. The 293 cells, seeded 18 hours before at 7.5Â10 5 cells in a 60 -mm dish, were transfected with linearized plasmid DNA using the CaPO 4 Mammalian Transfection kit (Stratagene ) . After 24 hours, cells were divided 1:4 and allowed to attach before overlaying with DME /agar containing 2% fetal calf serum. Plaques were picked and virus eluted in 0.5 mL media; virus was then subjected to a second round of plaque purification.
PCR analysis of viral plaques
Duplicate cultures of 293 cells, seeded at 1Â10 5 cells per well in 24-well plates, were infected using 0.25 mL virus. When the cells were rounded up, half the wells was washed with PBS, cells were lysed using Hirt lysis buffer ( 0.6% SDS /50 mM Tris -HCl, pH 7.4/ 10 mM EDTA ), scraped into Eppendorf tubes, adjusted to 1 M NaCl, and placed at 48C overnight. The plates with the remaining wells were subjected to three rounds of freeze -thawing to produce a virus lysate. After 18-24 hours, the Hirt lysates were centrifuged (14,000 rpm, 30 minutes, RT ), the supernatants were transferred into fresh tubes, isopropanol precipitated, centrifuged as above, washed twice with 70% ethanol, and resuspended in 50 L of 10 mM Tris, pH 8. Approximately 100 ng of Hirt DNA was used in a PCR reaction to screen for the presence of vhs sequences.
Detection of vhs protein
U -87MG cells (ATCC ) , a human glioblastoma cell line, were seeded in 24-well plates at 1Â10 5 cells per well and infected with virus amplified one time in 293 cells. At 5 days postinfection, a well of cells was lysed, fractionated by polyacrylamide gel electrophoresis, transferred to PVDF membrane, and subjected to immunoblot analysis 14 using a vhs -specific polyclonal antisera ( provided by G.S. Read, University of Missouri -Kansas City, Kansas City, MO ) .
Construction and analysis of 293 cells expressing vhs antisense RNA
The HSV-1 vhs gene was cloned into the mammalian expression vector, pcDNA3.1( À ) (Invitrogen ) as a KpnIXbaI fragment such that the RNA expressed would be antisense to the vhs RNA expressed from the adenovirus vector. The plasmid DNA was linearized with BglII and used to transfect 293 cells by calcium phosphate -mediated precipitation. The following day, cells were passaged at ratios ranging from 1:4 to 1:20; 24 hours later, G418 was added at a concentration of 800 g /mL. G418 -resistant colonies were picked, expanded, and analyzed for the expression of antisense vhs RNA. Total cellular RNA was isolated from 10 7 cells using the RNeasy mini kit ( Qiagen ) . Aliquots of RNA were reverse-transcribed using the Omniscript RT kit ( Qiagen ) with either oligo dT, or the vhs sense or antisense primers. The resulting DNA was subjected to 40 rounds of PCR amplification using the vhs -specific primers, followed by agarose gel analysis.
RESULTS
Construction and characterization of adenovirus vectors encoding vhs
We constructed a transfer vector, pTranvhs1, to generate recombinant adenoviruses containing the vhs gene under the control of the gfap promoter ( Fig 1A ) . We also cloned Ad5 sequences from nt 4281 through 35935 into pBR322, introducing a ClaI site at nt 35935, to yield the plasmid, pAd12 -100 ( Fig 1B ) . Recombinant adenoviruses containing the vhs transgene were generated by homologous recombination between the linearized transfer vector and virus backbone in transfected 293 cells ( Fig 1C ) . Virus plaques were picked and used to infect duplicate cultures of 293 cells. Viruses were screened for the presence of vhs sequences by PCR analysis of Hirt DNA extracted from the infected cells using primers specific for vhs. As a control for the production of recombinant virus, we also used the AdenoQuest expression system ( Quantum Biotechnologies ) . All four combinations of transfer vector and virus backbone were used to transfect 293 cells. Viruses containing the vhs transgene were obtained using both sources of virus backbone; however, the Quantum system was more efficient ( Table 1) .
We screened plaques positive by PCR for expression of vhs protein by immunoblot analysis of lysates of infected U -87MG cells. Infected cell lysates were subjected to immunoblot analysis using a vhs -specific polyclonal antisera. As seen in Figure 2A , vhs protein was expressed in HSV-1 infected human glioma cells, but not in mockinfected cells. A protein of slightly lower molecular mass was seen in cells infected with either Advhs2.22 or *ND = not determined. yTwenty -four of the first round plaques were screened for the presence of vhs sequences by PCR. zThree of the positive plaques were tested for protein expression. xSecond round plaque purification was carried out on one of the first round vhs -expressing plaques. Advhs2.24, but not in cells infected with Advhs2.23 or Advhs4.1 (Fig 2A ) . Detailed PCR analyses using all combinations of primers from the left end of the virus, including the ITR / signal, polyadenylation site, vhs, gfap promoter, and 9-23 map units (mu ) of Ad5, indicated that no rearrangements had taken place in any of the four recombinant viruses. Moreover, the vhs genes from Advhs2.22 and Advhs2.24 were sequenced and found to be wild type (data not shown) ; therefore, the difference in mobility of vhs is not due to the introduction of mutations during the construction of the recombinant adenoviruses. Two of the viruses, Advhs2.22 and Advhs4.1, were subjected to a second round of plaque purification. vhspositive plaques were obtained from the Advhs4.1 virus, which does not express vhs protein ( Table 1 ) . Furthermore, vhs -positive plaques were obtained following a third round of plaque purification (data not shown) . In contrast, none of the second round plaques obtained from the Advhs2.22 virus, which expresses vhs protein, contained vhs sequences ( Table 1 ) . While we examined a limited number of plaques in detail, we routinely screened first round plaques by PCR using primers specific for vhs and the 34 -37 mu region of adenovirus under conditions of a limiting amount of input template DNA. Although this is not quantitative, in our hands, a low vhs to 34 -37 mu ratio has proven to be indicative of a virus, which cannot be further plaquepurified. In contrast, a high vhs to 34 -37 mu ratio has proven to be indicative of a virus, which can be further plaquepurified. Several other first round viruses isolated on 293 cells expressed vhs protein, but had a low vhs to 34-37 mu ratio, and therefore were not pursued further ( data not shown) .
Expression of vhs protein in 293 cells
Leaky expression of vhs in the complementing 293 cells could prematurely shutoff their protein synthesis and preclude them from producing pure plaques of a vhsexpressing virus. We subjected lysates of infected 293 cells to immunoblot analysis as described above with the modification that bound antibody was detected by chemiluminescence using the SuperSignal 1 West Dura Extended Duration Substrate (Pierce, Rockford, IL ) . As seen in Figure  2B , vhs protein was detected in lysates of 293 cells infected with HSV-1, as well as in lysates of 293 cells infected with Advhs2.22 and Advhs2.24, but not with Advhs2.23. These results are similar to those obtained in infected U -87MG cells ( Fig 2A ) , and clearly show that vhs protein is expressed in the complementing 293 cells.
Construction and characterization of 293 cells expressing antisense RNA to vhs
Since we were unable to produce plaque -purified adenoviruses expressing vhs on standard 293 cells, we constructed a derivative of 293 cells that expresses an antisense RNA to vhs. The vhs gene was cloned into the mammalian expression vector, pcDNA3.1 ( À ) ( Invitrogen ) , in the antisense direction (Fig 3A ) . The resulting plasmid was transfected into 293 cells and G418 -resistant colonies were obtained. Isolated clones were screened for the expression of antisense RNA by RT-PCR using oligo dT as a primer for the RT reaction followed by PCR amplification using primers specific for the vhs gene. Over half of the G418 -resistant clones expressed a 500 -600 nt RNA (data not shown ) ; we further analysed the four clones that expressed the highest GLENN AND CHATTERJEE: 293 CELLS EXPRESSING VHS ANTISENSE RNA amounts of this RNA. Total cellular RNA was first reversetranscribed using either oligo dT as a primer, or primers that would detect either antisense or sense vhs RNA, and then PCR -amplified using primers specific to the vhs gene. In each cell line, a 500-600 nt PCR product was detected following reverse transcription using either oligo dT or the antisense oligonucleotide as a primer ( Fig 3B ) . In contrast, only a faint PCR product was obtained following reverse transcription using the sense primer ( Fig 3B ) . No PCR product was obtained in PCR reactions carried out without prior reverse transcription (Fig 3B ) . Interestingly, the RNA expressed is much smaller than the expected 1.5 -kb vhs gene. We determined the structure of the antisense RNA by cloning and sequencing the RT-PCR product from three of the cell lines. The body of the RNA is 547 nt in length, comprising 419 nt from the 3 0 end of the vhs gene and 128 nt from the 5 0 end of the vhs gene ( Fig 3C ) . The RNA is spliced using consensus splicing signals found in the antisense direction of the vhs gene. Importantly, the antisense RNA contains the sequences spanning the translation start site from nt À 20 through + 108 relative to the AUG in the sense direction (Fig 3C ) .
Generation of adenovirus vectors expressing vhs on 293vhs AS cells
We transfected the 293vhs AS cells with the transfer vector and the adenovirus backbone as before and generated first round plaques of recombinant virus containing the vhs gene. We screened 70 first round plaques for presence of vhs sequences by PCR analysis of Hirt supernatant DNA; 63 of these were positive ( Table 2 ) . Fourteen of the positive plaques were screened for the expression of vhs by immunoblot analysis; four of them expressed vhs protein ( Table 2) and were subjected to a second round of plaque purification. Each of the viruses gave rise to vhs -positive second round plaques, some of which still expressed vhs protein (Table 2) . Viruses, which expressed vhs protein, were carried through a third round of plaque purification. One of these viruses gave rise to third round plaque -purified viruses, all of which were positive for vhs sequences ( 20 of 20 ) and expression of vhs protein ( seven of seven ) ( Fig 2C,  Table 2 ). Thus, the 293 cells expressing antisense RNA to vhs enabled us to produce and plaque -purify recombinant adenoviruses expressing vhs protein. We have produced 10 and 90 mL infected cultures of Advhs on 293vhs AS cells without generating replication -competent adenovirus ( RCA ) as judged by PCR analysis of viral DNA from infected HeLa cells for the presence of E1A sequences (data not shown ). This is encouraging; however, one may have to start with producer cells in which the E1A and E1B genes are unlinked to help ensure the absence of RCA.
In a preliminary experiment, Advhs was two to three times more effective than a control virus expressing GFP at killing U -87MG cells. Approximately 40% of the cells was killed within 24 hours (data not shown) .
DISCUSSION
There are several approaches that one could take to produce recombinant adenovirus vectors expressing a toxic or proapoptotic transgene. The two basic approaches involve modifying either the vector or the complementing cell line. One could use a tissue -specific promoter in an attempt to limit expression of the transgene. We introduced the vhs gene of HSV-1 into an adenovirus vector under the control of the murine gfap promoter to direct tissue -specific expression of the transgene. Several groups have reported using either the human gfap promoter 3,15 -17 or the murine myelin basic protein promoter 18 to direct expression of a suicide gene in glioblastomas. The human gfap promoter resides in a 2.2-kb fragment of DNA and could thus account for an appreciable amount of the coding capacity of many recombinant viral vectors. All of the elements required for tissue -specific expression of the murine gfap gene are found within 300 nucleotides of the transcription start site. 19 Thus, its compact size could make it more amenable to the construction of gene therapy vectors. However, as seen in this case, inclusion of the gfap promoter did not allow us to produce vhsexpressing virus in 293 cells. Alternatively, one could place the transgene under the control of a regulatable promoter, such as the tetracycline -inducible promoter. While this system is inducible, in many cases, it also permits a low basal level of expression, which could limit its use in producing vectors expressing toxic or proapoptotic transgenes.
Another approach is to clone an expression cassette consisting of the neomycin resistance gene and a polyadenylation signal flanked by loxP sites between the promoter and the transgene. 20, 21 Transcripts expressed in 293 cells would be processed in such a way that the toxic transgene was removed and, therefore, not expressed. Cells coinfected with the vector and a second virus encoding Cre recombinase would contain viruses with the sequences between the loxP sites excised, allowing expression of the transgene in the appropriate cells. In this case, one would have to infect with two vectors, which may not be desirable in all situations.
Instead of modifying the vector, one could also modify the complementing cell line. Adenovirus vectors are traditionally produced on 293 cells, which complement the E1 region deleted in the vector. Three groups have constructed modified 293 cells, which express the antiapoptotic CrmA gene from baculovirus, enabling them to produce adenoviruses expressing Fas ligand. 11 -13 CrmA protects cells from apoptosis by inhibiting the activity of various proapoptotic caspases. Since vhs is an RNase and would presumably also degrade CrmA mRNA, we were not certain that 293 CrmA cells would help in producing recombinant virus. There are three modifications of 293 cells that we considered. First, one could express an antisense RNA to vhs. Second, one could express a ribozyme directed against vhs RNA. Or third, one could express a truncated form of vp16 lacking the acidic transactivation domain. Vp16 is a potent transactivating protein encoded by HSV; it also interacts with vhs protein, inhibiting its activity, 22 and forms of vp16 that lack the acidic activation domain can still bind and inhibit vhs activity. We decided to try the first approach, largely because the starting materials were readily available and it would be most applicable to other transgenes. In sharp contrast to the situation using 293 cells, we were able to produce and plaque -purify recombinant adenoviruses expressing vhs in the 293vhs AS cells.
The vhs protein expressed from the adenovirus vector had a smaller apparent molecular weight than that expressed in HSV-infected cells. vhs is phosphorylated and there are multiple forms of the protein. 7, 23 Since there are multiple differently migrating forms of vhs protein found in the context of an HSV infection, it is possible that the vhs protein expressed from the recombinant adenovirus is modified differently, leading to its faster migration.
Adenovirus type 5 poorly infects glioblastoma cells isolated directly from tumors, and thus would not be expected to efficiently infect tumor cells in the patient. Therefore, the vhs gene would have to be introduced in a targeted vector. One could use a mutant fiber protein containing a stretch of lysine residues at the carboxy terminus. 24 Alternatively, chlorotoxin, a small peptide isolated from scorpion venom, could be used as a targeting ligand. 25 Previous reports show that expression of vhs reduces expression from a cotransfected reporter plasmid 8, 9 or the yield of HIV in transfected cells. 10 Thus, it was suggested that vhs could be used as a suicide gene for HIV gene therapy. It is important to note that these studies used vhs expressed from plasmid DNA in transiently transfected cells. Significantly, we have taken these studies a step further by devising a method to produce an adenovirus vector expressing the vhs gene under the control of the gfap promoter. The apparent toxicity we observed in recombinant vectors, which express vhs protein, supports the notion that vhs can be adapted for use as a suicide gene. 293 cells expressing an antisense RNA to the transgene represent a novel approach to producing adenovirus vectors expressing a toxic transgene.
